ClinicalTrials.gg
RecruitingNCT07582510TELE-MEUpdated May 18, 2026

Telerehabilitation vs Supervised Physiotherapy for Medial Epicondylitis

An interventional study of Telerehabilitation Exercise Program and Supervised Physiotherapy Program in Medial Epicondylitis, Telerehabilitation and Physiotherapy, sponsored by Benha University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Benha University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This randomized controlled trial aims to compare the effectiveness of telerehabilitation and supervised physiotherapy in patients with medial epicondylitis. The primary outcome is improvement in pain and function using the Patient-Rated Elbow Evaluation (PREE). Secondary outcomes include pain intensity, grip strength, musculoskeletal ultrasound findings, adherence, and upper limb disability measured by Quick DASH.

Read the detailed description

Medial epicondylitis is a tendinopathy affecting the common flexor origin of the elbow, resulting in pain and functional limitation. Supervised physiotherapy is commonly used; however, telerehabilitation provides an accessible and scalable alternative. Evidence comparing these two delivery models is limited.

This randomized controlled trial will compare telerehabilitation and supervised physiotherapy over an 8-week intervention period. Clinical outcomes will be assessed using PREE, pain intensity, grip strength, and QuickDASH. Musculoskeletal ultrasound will be used to evaluate tendon structural characteristics. The study will also explore the relationship between imaging findings and clinical outcomes.

02

Conditions studied

  • Medial Epicondylitis
  • Telerehabilitation
  • Physiotherapy

Browse trials for

Keywords

  • medial epicondylitis
  • telerehabilitation
  • grip strength
  • Patient-Rated Elbow Evaluation
  • Quick DASH
03

In context

Elbow Tendinopathy

26 studies on the registry are indexed under Elbow Tendinopathy; 9 are open to participants now.

This study's planned enrollment of 60 is above the median of 40 across 23 interventional studies indexed under Elbow Tendinopathy.

Browse Elbow Tendinopathy studies →

Lead sponsor

Benha University is the lead sponsor of 362 studies on the registry; 66 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 60 years
  • Clinical diagnosis of medial epicondylitis
  • Symptoms duration ≥6 weeks
  • Pain with resisted wrist flexion
  • Local tenderness at medial epicondyle

Exclusion criteria

Exclusion Criteria:

  • Previous elbow surgery
  • injection within the past 3 months
  • Cervical radiculopathy
  • Systemic inflammatory disease
  • Bilateral symptoms
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Telerehabilitation

    Participants will receive a structured home-based rehabilitation program delivered through digital platforms with weekly remote supervision.

    Other: Telerehabilitation Exercise Program

  • Active comparator
    Supervised Physiotherapy

    Participants will receive clinic-based physiotherapy sessions including supervised exercises.

    Other: Supervised Physiotherapy Program

Interventions

  • OtherTelerehabilitation Exercise Program

    Participants will perform a home-based progressive loading program targeting the wrist flexor-pronator muscles three times per week for 8 weeks. The protocol will progress from isometric exercises in weeks 1-2 (4-5 × 30-45 s holds), to eccentric loading in weeks 3-4 (3 × 15 repetitions), followed by combined concentric-eccentric training in weeks 5-6 (3-4 × 10-12 repetitions), and heavy slow resistance in weeks 7-8 (3-4 × 6-8 repetitions at \~70-85% 1RM). Exercise intensity will be guided by a pain-monitoring model (≤5/10), with progression based on tolerance. Participants will receive weekly video consultations, instructional materials, and adherence will be tracked via digital logs.

  • OtherSupervised Physiotherapy Program

    Participants will undergo an identical progressive loading program targeting the wrist flexor-pronator muscles, administered three times per week for 8 weeks under direct physiotherapist supervision. The intervention will follow the same staged progression: will progress from isometric exercises in weeks 1-2 (4-5 × 30-45 s holds), to eccentric loading in weeks 3-4 (3 × 15 repetitions), followed by combined concentric-eccentric training in weeks 5-6 (3-4 × 10-12 repetitions), and heavy slow resistance in weeks 7-8 (3-4 × 6-8 repetitions at \~70-85% 1RM). Exercise intensity will be guided by a pain-monitoring model (≤5/10), with progression based on tolerance. This supervised approach ensures correct technique, optimal load progression and adherence to the protocol

06

What researchers measure

Primary outcomes

  1. Change in Patient-Rated Elbow Evaluation (PREE) Score

    The PREE is a 15-item questionnaire assessing pain and functional disability. Scores range from 0 to 100, with higher scores indicating worse pain and function.

    Time frame: Baseline and 8 Weeks

Secondary outcomes

  1. Colour Ultrasonography

    Change in tendon hypervascularity and hypoechogenicity will be assessed using color Doppler ultrasonography and graded on a four-point scale (Grade 1-Grade 4). Ultrasonographic evaluation will include assessment of hypoechoic changes within the common flexor tendon, tendon sheath thickening, partial or full-thickness tendon ruptures, neovascularization detected by Doppler imaging, and cortical irregularities or damage at the medial epicondyle.

    Time frame: Baseline and 8 Weeks

  2. Grip Strength (hand dynamometer)

    Measured using a hand dynamometer. Hand grip strength will be assessed using a calibrated hydraulic hand dynamometer with participants seated comfortably, shoulder adducted and neutrally rotated, elbow flexed to 90°, forearm in neutral position, and wrist positioned between 0-30° extension according to standardized testing procedures. Participants will be instructed to perform maximal voluntary grip contraction for approximately 3-5 seconds. Three trials will be recorded for the affected upper limb with a 30-60 second rest interval between attempts, and the mean value in kilograms (kg) will be used for statistical analysis.

    Time frame: Baseline and 8 Weeks

  3. Pain Intensity (Visual Analog Scale)

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) ranging from 0 ("no pain") to 10 ("worst imaginable pain") at rest and during resisted wrist flexion.

    Time frame: Baseline and 8 Weeks

07

Study locations

1 of 1 sites recruiting
  • Outpatient clinic, faculty of Physical Therapy, Benha university
    Banhā, Benha 11503, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Nov 2026, 6 months after the start.

Of 18 interventional studies with no phase under Elbow Tendinopathy, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 25. This study's planned 6 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 3, 2026
First posted
May 13, 2026
StartActual
May 14, 2026
Primary completionEst.
Nov 15, 2026
CompletionEst.
Dec 15, 2026
Last update
May 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07582510
Lead sponsor
Benha University
Responsible party
Mahmoud Hamada Mohamed (Associate Professor of Physical Therapy, Benha University) — Principal investigator
First posted
May 13, 2026
Start date
May 14, 2026
Primary completion
Nov 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
May 18, 2026

Study contacts

Mahmoud Hamada Mohamed Associate Professor, Ph.D
Contact
mahmoud.mohamed@fpt.bu.edu.eg
01096968910

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion